It is clear that issues surrounding atherosclerosis and cardiovascular health in patients living with HIV will become increasingly important over the next decade, for the reasons discussed above.

HIV-infected children represent a uniquely vulnerable group, particularly when long-term exposure to antiretroviral therapy precipitates metabolic complications. Among these, dyslipidaemia and insulin ...

Individuals with HIV have a higher prevalence of MASLD and dyslipidemia compared to controls, but are not more metabolically ill overall. The study used a case-control design with 60 HIV-positive ...

ART is crucial for HIV management but can lead to significant weight gain, affecting quality of life and adherence. A study found 24% of participants experienced a 5% or greater weight gain, ...